Literature DB >> 6400436

Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles.

P G Cavanaugh, B F Sloane, A S Bajkowski, G J Gasic, T B Gasic, K V Honn.   

Abstract

Murine 15091A mammary adenocarcinoma cells and membrane vesicles spontaneously shed from these tumor cells in culture can induce aggregation of washed human platelets. A spectrum of proteinase inhibitors was tested for their ability to inhibit 15091A induced platelet aggregation. Of the inhibitors tested the most effective were those selective for cysteine proteinases. The effect of the spectrum of proteinase inhibitors on 15091A induced platelet aggregation was compared to the effect on cathepsin B-like cysteine proteinase activity in homogenates of 15091A tumor cells and their spontaneously shed vesicles. The results suggest that there is a correlation between activity of a cathepsin B-like proteinase in 15091A cells and vesicles and the ability of these cells and vesicles to induce aggregation of washed human platelets.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6400436     DOI: 10.1007/BF00121192

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

1.  Platelet aggregating material in mouse tumor cells. Removal and regeneration.

Authors:  G J Gasic; T B Gasic; S A Jimenez
Journal:  Lab Invest       Date:  1977-04       Impact factor: 5.662

2.  Antimetastatic effects associated with platelet reduction.

Authors:  G J Gasic; T B Gasic; C C Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

3.  Tumor shedding and coagulation.

Authors:  H F Dvorak; S C Quay; N S Orenstein; A M Dvorak; P Hahn; A M Bitzer; A C Carvalho
Journal:  Science       Date:  1981-05-22       Impact factor: 47.728

4.  Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.

Authors:  K V Honn; P Cavanaugh; C Evens; J D Taylor; B F Sloane
Journal:  Science       Date:  1982-08-06       Impact factor: 47.728

5.  Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.

Authors:  H Kirschke; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

6.  Human cathepsin H.

Authors:  W N Schwartz; A J Barrett
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

7.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.

Authors:  B F Sloane; K V Honn; J G Sadler; W A Turner; J J Kimpson; J D Taylor
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

8.  A factor X-activating cysteine protease from malignant tissue.

Authors:  S G Gordon; B A Cross
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Authors:  E Pearlstein; C Ambrogio; G Gasic; S Karpatkin
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

View more
  14 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

Review 3.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

Review 4.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

Review 5.  Role of plasma, platelets, and endothelial cells in tumor metastasis.

Authors:  G J Gasic
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 6.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 7.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Danilo Millimaggi; Giulia Taraboletti; Gaspare Carta; Nicola Franceschini; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

9.  Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells.

Authors:  D G Menter; J S Hatfield; C Harkins; B F Sloane; J D Taylor; J D Crissman; K V Honn
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

10.  Cathepsin B: association with plasma membrane in metastatic tumors.

Authors:  B F Sloane; J Rozhin; K Johnson; H Taylor; J D Crissman; K V Honn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.